M&G Investment Management’s Quest Diagnostics DGX Stock Holding History

M&G Investment Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$51.8M	Sell	375,702 -20,224	-5%	-$2.66M	0.18%	73
2023 Q3	$48.3M	Buy	395,926 +20,550	+5%	+$2.74M	0.22%	76
2023 Q2	$52.9M	Sell	375,376 -122,606	-25%	-$16.9M	0.21%	79
2023 Q1	$70.2M	Sell	497,982 -7,408	-1%	-$1.06M	0.33%	62
2022 Q4	$78.8M	Buy	505,390 +10,263	+2%	+$1.47M	0.39%	58
2022 Q3	$60.9K	Buy	495,127 +24,532	+5%	+$3.23M	0.35%	65
2022 Q2	$62.6K	Sell	470,595 -8,054	-2%	-$1.1M	0.37%	70
2022 Q1	$65.6K	Buy	478,649 +114,325	+31%	+$15.9M	0.13%	71
2021 Q4	$63K	Buy	364,324 +52,905	+17%	+$8.05M	0.16%	73
2021 Q3	$45.2K	Buy	311,419 +1,516	+0.5%	+$222K	0.11%	120
2021 Q2	$40.9K	Buy	309,903 +12,712	+4%	+$1.66M	0.1%	116
2021 Q1	$38K	Buy	297,191 +35,511	+14%	+$4.38M	0.12%	88
2020 Q4	$31.1K	Sell	261,680 -15,211	-5%	-$1.85M	0.19%	98
2020 Q3	$31.6M	Buy	276,891 +21,802	+9%	+$2.58M	0.31%	88
2020 Q2	$29.1M	Buy	255,089 +17,732	+7%	+$1.88M	0.31%	85
2020 Q1	$19M	Buy	237,357 +25,877	+12%	+$2.68M	0.23%	99
2019 Q4	$22.6M	Buy	+211,480	New	+$22.1M	0.2%	106

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

M&G Investment Management's DGX Position: Q4 2023 in Review

M&G Investment Management reduced its Quest Diagnostics (DGX) stake by 5.1% in Q4 2023, selling an estimated $2.66M and leaving 375,702 shares worth $51.8M. The position accounts for 0.18% of the portfolio, ranked #73.

M&G Investment Management first reported a position in DGX in Q4 2019 and has held it in 17 quarters since. The position peaked at $78.8M in Q4 2022. 826 funds tracked by Wall St. Rank hold DGX as of Q4 2023.

M&G Investment Management held 375,702 shares of Quest Diagnostics worth $51.8M as of Q4 2023.
M&G Investment Management sold 20,224 Quest Diagnostics shares in Q4 2023, an estimated $2.66M.
Quest Diagnostics made up 0.18% of M&G Investment Management's portfolio in Q4 2023, its #73 holding.
M&G Investment Management first reported a position in Quest Diagnostics in Q4 2019 and has held it in 17 quarters since.
M&G Investment Management's Quest Diagnostics position peaked at $78.8M in Q4 2022.
826 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2023.

Based on M&G Investment Management's 13F filing for Q4 2023, filed 8 Feb 2024.